Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page
- Check2 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, signaling a minor platform update to the study page. This change reflects backend/content refresh rather than any new information about the trial itself.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision: v3.6.2 was added to the page and the previous v3.6.0 entry was removed, updating the study record's version history. This reflects an updated page version without altering study data or content.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedAdded recruitment status indicating that the study is no longer recruiting participants. New help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) were introduced, and the revision/versioning was updated to v3.6.0 while the older heading and revision note were removed.SummaryDifference0.3%

- Check31 days agoChange DetectedThe page shows an updated revision tag (v3.5.5) replacing the previous v3.5.4, indicating a new version of the page's metadata.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page revision label was updated from Revision: v3.5.3 to Revision: v3.5.4, representing a newer page version. This update pertains to metadata/formatting rather than substantive study details.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page’s footer has been updated to indicate the ClinicalTrials.gov site revision was bumped from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.